Fig. 18
From: Multimodality imaging features of desmoid tumors: a head-to-toe spectrum
Chest posterior wall DT (T2wi (a) and after contrast T1wi (d)). A 23-year-old female patient underwent chemotherapy. MRI showed progressive decrease of T2wi signal intensity and contrast enhancement on T1wi of the lesion (white arrow): during therapy, the lesion decreased in dimension and in T2 hyperintensity (b) but maintained moderate contrast enhancement on T1wi (e). After 4 years, the lesion significantly reduced its dimension, become hypointense on T2wi (c), and did not show significant contrast enhancement (f)